Evaluation of Portal Vein Thrombosis in Liver Graft Ten Years After Liver Transplantation Due to Budd–Chiari Syndrome Using Doppler Ultrasound
Azra Husic-Selimovic, Srdjan Gornjakovic, Marcus Schuchmann, Zora Vukobrat-Bijedic
Acta Inform Med. 2012; 20(3): 194-195
Budd-Chiari syndrome is a rare but life-threatening disorder characterized by obstruction of the hepatic venous outflow. Treatment depends on underlying cause, extent of the obstruction and functional capacity of the liver. When all other therapy options are unsuccessful, liver transplant should be considered. Portal vein thrombosis (PVT) is a frequent event in patients with cirrhosis which can be treated with anticoagulants, but there are limited data regarding safety and efficacy of this approach.
1. Huard G, Bilodeau M. Management of Anticoagulation for Portal Vein Thrombosis in Individuals with Cirrhosis: A Systematic Review. Int J Hepatology. 2012; 2012: 672986. Epub 2012 Jun 20.
2. Rodriguez-Castro KI, Simioni P, Burra P, Senzolo M. Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis. Liver Int. 2012 Jun 27.
3. Rodriguez-Castro KI, Simioni P, Burra P, Senzolo M. Optimal length of anticoagulant therapy in cirrhotic patients with portal vein thrombosis. Liver Int. 2012 Jun 27.